132 related articles for article (PubMed ID: 28188757)
1. Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer.
Gunlusoy B; Ceylan Y; Koskderelioglu A; Gedizlioglu M; Degirmenci T; Ortan P; Kozacioglu Z
Urology; 2017 May; 103():167-172. PubMed ID: 28188757
[TBL] [Abstract][Full Text] [Related]
2. The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study.
Ceylan Y; Gunlusoy B; Koskderelioglu A; Gedizlioglu M; Degirmenci T
Aging Male; 2020 Dec; 23(5):733-739. PubMed ID: 30924381
[TBL] [Abstract][Full Text] [Related]
3. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study.
Yang J; Zhong F; Qiu J; Cheng H; Wang K
Eur J Cancer Care (Engl); 2015 Mar; 24(2):198-204. PubMed ID: 25711542
[TBL] [Abstract][Full Text] [Related]
5. Androgen-deprivation therapy impairs left ventricle functions in prostate cancer patients.
Kanar BG; Ozben B; Sunbul M; Şener E; Ozkan O; Tınay I; Tigen MK
Int Urol Nephrol; 2019 Jul; 51(7):1107-1112. PubMed ID: 31165396
[TBL] [Abstract][Full Text] [Related]
6. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
[TBL] [Abstract][Full Text] [Related]
7. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
[TBL] [Abstract][Full Text] [Related]
9. Physical function in men with prostate cancer on androgen deprivation therapy.
Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Kilgour A; Lau YK
BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
[TBL] [Abstract][Full Text] [Related]
11. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
12. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
Messing EM; Manola J; Yao J; Kiernan M; Crawford D; Wilding G; di'SantAgnese PA; Trump D;
Lancet Oncol; 2006 Jun; 7(6):472-9. PubMed ID: 16750497
[TBL] [Abstract][Full Text] [Related]
13. Locally advanced prostate cancer: effective treatments, but many adverse effects.
Prescrire Int; 2013 Jan; 22(134):18-20, 22-3. PubMed ID: 23367679
[TBL] [Abstract][Full Text] [Related]
14. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.
Wu LM; Diefenbach MA; Gordon WA; Cantor JB; Cherrier MM
Urol Oncol; 2013 Nov; 31(8):1533-8. PubMed ID: 22975107
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Radical Prostatectomy Plus Extended Lymph Node Dissection in Combination With Immediate Androgen Deprivation Therapy for Cases of pT3-4N0-1M0 Prostate Cancer: A Multimodal Study of 8 Years' Follow-up.
Yang Y; Luo Y; Hou GL; Huang QX; Pang J; Gao X
Clin Genitourin Cancer; 2016 Aug; 14(4):e321-7. PubMed ID: 26691668
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
[TBL] [Abstract][Full Text] [Related]
17. Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy: A cross-sectional study.
Yang J; Zhong F; Qiu J; Wang K
Asia Pac J Clin Oncol; 2015 Dec; 11(4):277-81. PubMed ID: 25856786
[TBL] [Abstract][Full Text] [Related]
18. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.
Donovan KA; Walker LM; Wassersug RJ; Thompson LM; Robinson JW
Cancer; 2015 Dec; 121(24):4286-99. PubMed ID: 26372364
[TBL] [Abstract][Full Text] [Related]
19. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
20. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]